Funds › Exor N.V.
Exor N.V.
13F for Q3 2026, filed Nov 13, 2026. 7 positions worth $26.6B.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
$26.6B+$371.0M (1.4%) vs Q2 2026Q3 2026 · filed Nov 13
Latest report
Q3 2026
filed Nov 13, 2026
Reported value
$26.6B
+$371.0M (1.4%) vs Q2 2026
Positions
7
7 in Q2 2026
Top 10 share
100.0%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Holdings, Q3 2026
Largest first. Common shares only.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | RACE Ferrari N.V. | 37.77M | $14.8B | 55.8% | Unchanged | 13F ↗ |
| 2 | CNH CNH Industrial N.V. | 366.93M | $4.7B | 17.7% | Unchanged | 13F ↗ |
| 3 | 000000000 0 | 185.93M | $4.5B | 17.1% | Unchanged | 13F ↗ |
| 4 | STLA Stellantis N.V. | 449.41M | $2.0B | 7.4% | Unchanged | 13F ↗ |
| 5 | VIA Via Transportation, Inc. | 14.12M | $427.2M | 1.6% | Unchanged | 13F ↗ |
| 6 | CLVT Clarivate Plc | 67.29M | $112.4M | 0.4% | Unchanged | 13F ↗ |
| 7 | NMRA Neumora Therapeutics, Inc. | 4.22M | $2.5M | <0.1% | Unchanged | 13F ↗ |
Ten largest positions
By value, Q3 2026.
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer